Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel protein kinase B inhibitors and their use in cancer therapy reported by Amgen

Feb. 27, 2009

Tufts College presents new proteasome inhibitors potentially useful for treatment of cancer

Feb. 27, 2009

Bristol-Myers Squibb initiates phase II trial to compare BMS-690514 and erlotinib in NSCLC

Feb. 26, 2009

Genentech describes novel MEK kinase inhibitors in a recent patent

Feb. 26, 2009

AstraZeneca researchers describe new Axl and c-Met inhibitors

Feb. 25, 2009

GTx initiates phase I trial for GTx-758 in advanced prostate cancer

Feb. 24, 2009

New mTOR kinase inhibtors reported in recent AstraZeneca patents

Feb. 24, 2009

European Commission approves Firmagon for prostate cancer

Feb. 23, 2009

Endocyte begins phase II EC-145 trial for ovarian cancer

Feb. 23, 2009

GSK claims novel PI3Kalpha inhibitors with potential as anticancer agents

Feb. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...